Form 8-K Edwards Lifesciences For: Jul 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- US stock futures rise after previous session's selloff
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Edwards Lifesciences (EW) PT Raised to $120 at Oppenheimer
July 30, 2021 6:27 AM EDTOppenheimer analyst Suraj Kalia raised the price target on Edwards Lifesciences (NYSE: EW) to $120.00 (from $97.00) while maintaining an Outperform rating.
The analyst commented, "Edwards reported 2Q21 revenues of $1.38B vs. our/consensus' $1.29B/$1.28B estimates and guidance of $1.251.33B. TAVR revenues... More
